Sheridan Alyssa - NJ Morris, Morristown 07960

Sheridan Alyssa entered the industry of Nurse Practitioners in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 6213992, which describes it as a Nurse Practitioners. For further clarification, the SIC classifies this business under the code 8049 and described it as a Nurse Practitioners. The business provides service to the B2C market.

To acquire more information, please contact Alyssa Sheridan by calling (973) 267-9543 during business hours. You can also write to the business’ Single Location at 100 Madison Avenue, Morristown, New Jersey NJ 07960. You can also visit the company’s website at oncologyandhematology.net. View this business’ social media profiles on Twitter or on Facebbok .

Company: Sheridan Alyssa
Representative: Alyssa Sheridan
Place of Business: 100 Madison Avenue, Morristown, NJ 07960
Contact Number: (973) 267-9543
Website: oncologyandhematology.net
Type of Service: Nurse Practitioners
SIC Number: 8049
NAICS Number: 6213992
Locality: Single Location
Market Type: B2C (Business to Consumer)
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Sheridan Alyssa is a company operating from Morris, New Jersey providing professional Nurse Practitioners and relevant B2C variables. It was founded in 0 and registered with the SIC code 8049 as Nurse Practitioners, and with the NAICS code 6213992 as Nurse Practitioners.

With a current employee count of 1 to 4, Sheridan Alyssa has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Alyssa Sheridan at (973) 267-9543 for related queries, or to locate its Single Location using the coordinates 40.78787,-74.46391.

The Single Location can also be found at the street address 100 Madison Avenue in Morristown, New Jersey 07960 and can be engaged online through the company website at oncologyandhematology.net, the company Twitter , and Facebook page .